If/when GNBT receives funding for Covid-19, the amount of the funding matters. However, the significant force for GNBT will be credibility - something Anna stole. Many more people will know about this small pink-sheet company that owns 90% of NGIO and its science. That funding and resultant credibility will result in a surge in the PPS. If the funding is large, the credibility is large and the PPS will surge significantly - then seek its own level after a short time passes. The long-term outlook will then be up to Joe, the uplifting to NASDAQ, and how he and his new team handle the success.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links